UBS AM’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5M | Buy |
|
|||||
|
2025
Q1 | $10.1M | Sell |
|
|||||
|
2024
Q4 | $11.1M | Sell |
|
|||||
|
2024
Q3 | $16.6M | Sell |
|
|||||
|
2024
Q2 | $12.8M | Buy |
|
|||||
|
2024
Q1 | $9.7M | Buy |
|
|||||
|
2023
Q4 | $6.63M | Buy |
|
|||||
|
2023
Q3 | $1.19M | Buy |
|
|||||
|
2023
Q2 | $1.49M | Hold |
|
|||||
|
2023
Q1 | $1.49M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $230K | Sell |
|
|||||
|
2022
Q2 | $258K | Hold |
|
|||||
|
2022
Q1 | $773K | Hold |
|
|||||
|
2021
Q4 | $1.12M | Buy |
|
|||||
|
2021
Q3 | $489K | Hold |
|
|||||
|
2021
Q2 | $1.24M | Buy |
|
|||||
|
2021
Q1 | $648K | Buy |
|
|||||
|
2020
Q4 | $246K | Buy |
|